SALT LAKE CITY, May 24, 2011 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications, today announced the publication of an article in the May 2011 issue of the American Journal of Obstetrics and Gynecology that highlighted the innovative proteomic methods used by Drs. M. Sean Esplin and Steven W. Graves to identify novel biomarkers for the prediction of preterm birth.
